These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21816012)

  • 21. Efficacy and safety of entecavir in patients with chronic hepatitis B and advanced hepatic fibrosis or cirrhosis.
    Schiff E; Simsek H; Lee WM; Chao YC; Sette H; Janssen HL; Han SH; Goodman Z; Yang J; Brett-Smith H; Tamez R
    Am J Gastroenterol; 2008 Nov; 103(11):2776-83. PubMed ID: 18721244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term entecavir therapy of chronic severe hepatitis B.
    Chen J; Han JH; Liu C; Yu RH; Li FZ; Li QF; Gong GZ
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):261-6. PubMed ID: 19502165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B.
    Gish RG; Lok AS; Chang TT; de Man RA; Gadano A; Sollano J; Han KH; Chao YC; Lee SD; Harris M; Yang J; Colonno R; Brett-Smith H
    Gastroenterology; 2007 Nov; 133(5):1437-44. PubMed ID: 17983800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir.
    Leemans WF; Niesters HG; van der Eijk AA; Janssen HL; Schalm SW; de Man RA
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):773-7. PubMed ID: 18617782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of antiviral therapy on the survival of patients after major hepatectomy for hepatitis B virus-related hepatocellular carcinoma.
    Chan AC; Chok KS; Yuen WK; Chan SC; Poon RT; Lo CM; Fan ST
    Arch Surg; 2011 Jun; 146(6):675-81. PubMed ID: 21690443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changing landscape of antiviral resistance management in chronic hepatitis B.
    Nguyen T; Locarnini S; Desmond P
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1314-7. PubMed ID: 18853991
    [No Abstract]   [Full Text] [Related]  

  • 27. [Polymyositis with rimmed vacuoles in a case of chronic thyroiditis].
    Taniguchi A; Niwa A; Nakayama S; Hamaguchi Y; Kuzuhara S
    Rinsho Shinkeigaku; 1995 Apr; 35(4):403-7. PubMed ID: 7614767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Entecavir therapy against hepatitis B].
    Kato N; Omata M
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():340-4. PubMed ID: 15453342
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy.
    Pessôa MG; Gazzard B; Huang AK; Brandão-Mello CE; Cassetti I; Mendes-Corrêa MC; Soriano V; Phiri P; Hall A; Brett-Smith H
    AIDS; 2008 Sep; 22(14):1779-87. PubMed ID: 18753861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infection.
    Paredes AH; Lewis JH
    Ann Pharmacother; 2007 May; 41(5):880-4. PubMed ID: 17426078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of entecavir treatment for lamivudine-resistant hepatitis B over 3 years: histological improvement or entecavir resistance?
    Suzuki Y; Suzuki F; Kawamura Y; Yatsuji H; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Miyakawa Y; Kumada H
    J Gastroenterol Hepatol; 2009 Mar; 24(3):429-35. PubMed ID: 19226381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proper antiviral therapy for hepatitis B virus-associated acute-on-chronic liver failure.
    Liu T; Zhang C; Wang Y
    Hepatology; 2011 Aug; 54(2):747-8. PubMed ID: 21360719
    [No Abstract]   [Full Text] [Related]  

  • 33. [Polymyositis after interferon beta treatment of chronic hepatitis type C].
    Iguchi H; Kishi M; Fujioka T; Wakata N; Kinoshita M
    Rinsho Shinkeigaku; 1996 Jan; 36(1):22-4. PubMed ID: 8689784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Entecavir resistance is rare in nucleoside naïve patients with hepatitis B.
    Colonno RJ; Rose R; Baldick CJ; Levine S; Pokornowski K; Yu CF; Walsh A; Fang J; Hsu M; Mazzucco C; Eggers B; Zhang S; Plym M; Klesczewski K; Tenney DJ
    Hepatology; 2006 Dec; 44(6):1656-65. PubMed ID: 17133475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prednisolone priming enhances Th1 response and efficacy of subsequent lamivudine therapy in patients with chronic hepatitis B.
    Liaw YF; Tsai SL; Chien RN; Yeh CT; Chu CM
    Hepatology; 2000 Sep; 32(3):604-9. PubMed ID: 10960456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Results of 3 years of continuous entecavir treatment in nucleos(t)ide-naive chronic hepatitis B patients].
    Yao GB; Ren H; Xu DZ; Zhou XQ; Jia JD; Wang YM; Chen CW
    Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):881-6. PubMed ID: 20038326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: the case for continuous antiviral therapy.
    Shouval D; Lai CL; Chang TT; Cheinquer H; Martin P; Carosi G; Han S; Kaymakoglu S; Tamez R; Yang J; Tenney D; Brett-Smith H
    J Hepatol; 2009 Feb; 50(2):289-95. PubMed ID: 19070393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinilal study of medical ozone therapy in chronic hepatitis B of 20 patients].
    Jiao XJ; Peng X
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec; 22(6):484-5. PubMed ID: 19544653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of the therapeutical effects of entecavir and lamvudine in treatment of HBeAg-positive chronic hepatitis B].
    Hou HB; Deng LN; Li CP; Liu XR; Liu FQ
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):873-4. PubMed ID: 19958652
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibody to hepatitis B e positive hepatitis induced by withdrawal of steroid therapy for polymyositis: response to interferon-alpha and cyclosporin A.
    Nakanishi K; Ishikawa M; Nakauchi M; Sakurai A; Doi K; Taniguchi Y
    Intern Med; 1998 Jun; 37(6):519-22. PubMed ID: 9678685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.